Pharmacotherapy patterns in the treatment of bipolar disorder

Bipolar Disorders

Volumn 4, Issue 6, 2002, Pages 366-377

  Russo, Patricia ^a   Smith, Mark W ^a   Dirani, Riad ^b   Namjoshi, Madhav ^b   Tohen, Mauricio ^b,c  

^a MEDSTAT GROUP   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Antipsychotic agents; Bipolar disorder; Medication therapy; Olanzapine

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG USE; DRUG WITHDRAWAL; FEMALE; GENDER; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MENTAL DISEASE; MULTIVARIATE ANALYSIS; PHARMACY; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG MONITORING; DRUG THERAPY; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES;

EID: 0036922995     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2002.01216.x     Document Type: Article

References (19)

1. Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59 (Suppl. 1): 38-48.
2. Mental health. A report of the Surgeon General. Washington, DC: US Government Printing Office, 1999.
3. Zarate CA Jr. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry 2000; 61 (Suppl. 8): 52-61.
4. Goodwin F, Jamison K. Manic-Depressive Illness. New York, NY: Oxford University Press, 1990.
5. Vieta E, Gasto C, Colom F et al. Treatment of refactory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol 1999; 14: 339-343.
6. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339-343.
7. Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
8. Frye MA, Ketter TA, Altshuler LL et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 1998; 48: 91-104.
9. Sharma V, Pistor L. Treatment of bipolar mixed state with olanzapine. J Psychiatry Neurosc 1999; 24: 40-44.
10. McElroy S, Frye M, Denicoff K, Altshuler L, Nolen W, Kubka R. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord 1998; 49: 119-122.
11. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The expert consensus guidelines series: medication treatment of bipolar disorder. Postgrad Med 2000; 157: 124-126.
12. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Sliotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157: 124-126.
13. Licht RW. Drug treatment of mania: a critical review. Acta Psychiatr Scand 1998; 97: 387-397.
14. Frye MA, Ketter TA, Leverich GS et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61: 9-15.
15. Tohen M, Zhang F, Taylor CC et al. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. J Affect Disord 2001; 65: 85-93.
16. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21(3): 176-180.
17. McElroy SL, Frye M, Denicoff K et al. Olanzapine in treatment-resistent bipolar disorder. J Affect Disord 1998; 49: 119-122.
18. Tohen M, Grundy S. Management of acute mania. J Clin Psychiatry 1999; 60 (Suppl. 5): 31-34.
19. Ghaemi SN, Goodwin FK. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychophamacol 1999; 19(4): 354-361.